Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;35(7):6739-48.
doi: 10.1007/s13277-014-1851-y. Epub 2014 Apr 9.

Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India

Affiliations
Free article

Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India

Biswadeep Choudhury et al. Tumour Biol. 2014 Jul.
Free article

Abstract

Head and neck squamous cell carcinoma (HNSCC) diagnosis involves histopathological investigations with intervention procedures. Widely accepted biochemical panels for HNSCC detection is not available yet. We tried to find out the effectiveness of the serum-based biochemical markers for their prognostic significance in HNSCC. We collected fresh blood samples of 80 HNSCC patients and 100 healthy subjects. Samples were analyzed for absolute levels of arginase (ARG), ornithine aminotransferase (OAT), catalase (CAT), lactate dehydrogenase (LDH), amylase (AMY) activity, and C-reactive protein (CRP). Receiver-operator characteristic curves and Fagan's nomograms were generated. Out of six parameters studied, four (OAT, CAT, LDH, and AMY) did not show biologically significant differences to be used as biomarkers. Significant elevation in serum ARG and CRP levels were observed in HNSCC. The individual estimation of ARG and CRP showed lower specificity, but their combination improved the specificity level to 95%. Our results suggest that serum ARG and CRP together can efficiently diagnose HNSCC.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Pharmacol. 2011 Nov 15;82(10):1384-90 - PubMed
    1. Int J Oncol. 2008 Feb;32(2):357-65 - PubMed
    1. Head Neck Oncol. 2010 Aug 02;2:21 - PubMed
    1. Onkologie. 2012;35(10):570-4 - PubMed
    1. Cancer Causes Control. 2013 Dec;24(12):2077-87 - PubMed

Publication types

LinkOut - more resources